226 related articles for article (PubMed ID: 21268285)
21. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A
Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235
[TBL] [Abstract][Full Text] [Related]
22. Effects of Pathogenic Variations in the Human Rhodopsin Gene (hRHO) on the Predicted Accessibility for a Lead Candidate Ribozyme.
Froebel BR; Trujillo AJ; Sullivan JM
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3576-3591. PubMed ID: 28715844
[TBL] [Abstract][Full Text] [Related]
23. Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.
Orlans HO; Barnard AR; Patrício MI; McClements ME; MacLaren RE
Hum Gene Ther; 2020 Jul; 31(13-14):730-742. PubMed ID: 32394751
[TBL] [Abstract][Full Text] [Related]
24. Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.
Zhang X; Girardot PE; Sellers JT; Li Y; Wang J; Chrenek MA; Wu W; Skelton H; Nickerson JM; Pardue MT; Boatright JH
Mol Vis; 2019; 25():462-476. PubMed ID: 31523123
[TBL] [Abstract][Full Text] [Related]
25. Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa.
Greenwald DL; Cashman SM; Kumar-Singh R
Gene Ther; 2013 Apr; 20(4):425-34. PubMed ID: 22809998
[TBL] [Abstract][Full Text] [Related]
26. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa.
Olsson JE; Gordon JW; Pawlyk BS; Roof D; Hayes A; Molday RS; Mukai S; Cowley GS; Berson EL; Dryja TP
Neuron; 1992 Nov; 9(5):815-30. PubMed ID: 1418997
[TBL] [Abstract][Full Text] [Related]
27. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
Han Z; Banworth MJ; Makkia R; Conley SM; Al-Ubaidi MR; Cooper MJ; Naash MI
FASEB J; 2015 Jun; 29(6):2535-44. PubMed ID: 25713057
[TBL] [Abstract][Full Text] [Related]
28. Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15.
Botta S; de Prisco N; Marrocco E; Renda M; Sofia M; Curion F; Bacci ML; Ventrella D; Wilson C; Gesualdo C; Rossi S; Simonelli F; Surace EM
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263295
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach.
Gorbatyuk MS; Pang JJ; Thomas J; Hauswirth WW; Lewin AS
Mol Vis; 2005 Aug; 11():648-56. PubMed ID: 16145542
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa.
Wert KJ; Davis RJ; Sancho-Pelluz J; Nishina PM; Tsang SH
Hum Mol Genet; 2013 Feb; 22(3):558-67. PubMed ID: 23108158
[TBL] [Abstract][Full Text] [Related]
31. CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa.
Burnight ER; Wiley LA; Mullin NK; Adur MK; Lang MJ; Cranston CM; Jiao C; Russell SR; Sohn EH; Han IC; Ross JW; Stone EM; Mullins RF; Tucker BA
CRISPR J; 2023 Dec; 6(6):502-513. PubMed ID: 38108516
[TBL] [Abstract][Full Text] [Related]
32. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147
[No Abstract] [Full Text] [Related]
33. Abrupt onset of mutations in a developmentally regulated gene during terminal differentiation of post-mitotic photoreceptor neurons in mice.
Sandoval IM; Price BA; Gross AK; Chan F; Sammons JD; Wilson JH; Wensel TG
PLoS One; 2014; 9(9):e108135. PubMed ID: 25264759
[TBL] [Abstract][Full Text] [Related]
34. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.
Dryja TP; McGee TL; Hahn LB; Cowley GS; Olsson JE; Reichel E; Sandberg MA; Berson EL
N Engl J Med; 1990 Nov; 323(19):1302-7. PubMed ID: 2215617
[TBL] [Abstract][Full Text] [Related]
35. Gene augmentation for autosomal dominant retinitis pigmentosa using rhodopsin genomic loci nanoparticles in the P23H
Sp S; Mitra RN; Zheng M; Chrispell JD; Wang K; Kwon YS; Weiss ER; Han Z
Gene Ther; 2023 Aug; 30(7-8):628-640. PubMed ID: 36935427
[TBL] [Abstract][Full Text] [Related]
36. Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme.
Gorbatyuk M; Justilien V; Liu J; Hauswirth WW; Lewin AS
Exp Eye Res; 2007 Jan; 84(1):44-52. PubMed ID: 17083931
[TBL] [Abstract][Full Text] [Related]
37. Allele-specific gene-editing approach for vision loss restoration in
Liu X; Qiao J; Jia R; Zhang F; Meng X; Li Y; Yang L
Elife; 2023 Jun; 12():. PubMed ID: 37272616
[TBL] [Abstract][Full Text] [Related]
38. Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) mice.
Kennan A; Aherne A; Palfi A; Humphries M; McKee A; Stitt A; Simpson DA; Demtroder K; Orntoft T; Ayuso C; Kenna PF; Farrar GJ; Humphries P
Hum Mol Genet; 2002 Mar; 11(5):547-57. PubMed ID: 11875049
[TBL] [Abstract][Full Text] [Related]
39. Autosomal dominant retinitis pigmentosa with toxic gain of function: Mechanisms and therapeutics.
Narasimhan I; Murali A; Subramanian K; Ramalingam S; Parameswaran S
Eur J Ophthalmol; 2021 Mar; 31(2):304-320. PubMed ID: 32962414
[TBL] [Abstract][Full Text] [Related]
40. Dynamic in vivo quantification of rod photoreceptor degeneration using fluorescent reporter mouse models of retinitis pigmentosa.
Orlans HO; Barnard AR; MacLaren RE
Exp Eye Res; 2020 Jan; 190():107895. PubMed ID: 31816293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
